The Board of Directors of Nephrocare Health Services Limited, in their meeting held on May 19, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. According to the reported figures, the company’s revenue from operations for the quarter ended March 31, 2026, stood at 1,643.33 Million, compared to 1,606.64 Million in the previous quarter (December 31, 2025) and 1,450.12 Million in the corresponding quarter of the previous year (March 31, 2025). The comparative analysis indicates a revenue growth of 2.28% on a Quarter-on-Quarter (QoQ) basis and a significant increase of 13.32% on a Year-on-Year (YoY) basis.

Export to Sheets

Nephrocare Health Services Limited is a leading provider of comprehensive dialysis care, operating an extensive network of clinics that offer services ranging from diagnosis to treatment and wellness programs, including haemodialysis, home, and mobile dialysis. As of September 30, 2025, the company had established a strong footprint across India and internationally, with a network of 519 clinics, including 51 international clinics spanning the Philippines, Uzbekistan, and Nepal. The company is recognized as the largest dialysis service provider in India and Asia, leveraging an asset-light business model that emphasizes operational efficiency and quick expansion through greenfield, brownfield, and public-private partnership (PPP) modes.